Related references
Note: Only part of the references are listed.IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Fengming Ding et al.
FRONTIERS IN IMMUNOLOGY (2022)
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
Ahmed J. Yousuf et al.
LANCET RESPIRATORY MEDICINE (2022)
IL-33 in COPD: the hunt for responder subgroups
Dave Singh
LANCET RESPIRATORY MEDICINE (2022)
Blood Eosinophils and Chronic Obstructive Pulmonary Disease A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review
Dave Singh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease
Archana Shankar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Pharmacological approaches to target type 2 cytokines in asthma
Laurent Guilleminault et al.
PHARMACOLOGY & THERAPEUTICS (2022)
IgE is associated with exacerbations and lung function decline in COPD
Marek Lommatzsch et al.
RESPIRATORY RESEARCH (2022)
Role of Atypical Chemokines and Chemokine Receptors Pathways in the Pathogenesis of COPD
Francesco Nucera et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease
Andrew Higham et al.
ALLERGY (2021)
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease A Randomized, Double-Blind, Multicenter, Parallel-Group Study
Fernando J. Martinez et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
IL-17C contributes to NTHi-induced inflammation and lung damage in experimental COPD and is present in sputum during acute exacerbations
Giovanna Vella et al.
PLOS ONE (2021)
Prospects for COPD treatment
Maria Gabriella Matera et al.
CURRENT OPINION IN PHARMACOLOGY (2021)
Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial
Christopher E. Brightling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Natural history and mechanisms of COPD
Peter Lange et al.
RESPIROLOGY (2021)
Asthma in the Precision Medicine Era: Biologics and Probiotics
Chiao-Juno Chiu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Classes of drugs that target the cellular components of inflammation under clinical development for COPD
Maria Gabriella Matera et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2021)
Preclinical studies and the function of IL-17 cytokines in COPD
Felix Ritzmann et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2021)
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
Ian D. Pavord et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2021)
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
Klaus F. Rabe et al.
LANCET RESPIRATORY MEDICINE (2021)
An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
Mario Cazzola et al.
BIOLOGICS-TARGETS & THERAPY (2021)
Targeted therapy in eosinophilic chronic obstructive pulmonary disease
Mathieu Fieldes et al.
ERJ OPEN RESEARCH (2021)
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
Benjamin David et al.
THORAX (2021)
Eosinophilic Granulomatosis with Polyangiitis with Pulmonary and Cardiac Involvement
J. C. Kamp et al.
PNEUMOLOGIE (2021)
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies
Gerard J. Criner et al.
LANCET RESPIRATORY MEDICINE (2020)
Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD
Emmanuel T. Osei et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
TSLP Inhibitors for Asthma: Current Status and Future Prospects
Maria Gabriella Matera et al.
DRUGS (2020)
IL-13 and IL-4, but not IL-5 nor IL-17A, induce hyperresponsiveness in isolated human small airways
Martijn L. Manson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab
Luigino Calzetta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
IL-33 in Chronic Respiratory Disease: From Preclinical to Clinical Studies
Chantal Donovan et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Eosinophil-derived IL-13 promotes emphysema
Alfred D. Doyle et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report
Vanessa M. McDonald et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Airway inflammation in COPD: progress to precision medicine
Christopher Brightling et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
T2 Biologics for Chronic Obstructive Pulmonary Disease
Ahmed Yousuf et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers
Mario Cazzola et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
IL-33 Mediated Inflammation in Chronic Respiratory Diseases-Understanding the Role of the Member of IL-1 Superfamily
Agata Gabryelska et al.
FRONTIERS IN IMMUNOLOGY (2019)
Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO
Nicola A. Hanania et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Association between tumor necrosis factor-α and chronic obstructive pulmonary disease: a systematic review and meta-analysis
Yang Yao et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Uses of biologics in allergic diseases What to choose and when
Tara Vinyette Saco et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis
Paola Rogliani et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)
The role of Th1/Th2 cytokines played in regulation of specific CD4 + Th1 cell conversion and activation during inflammatory reaction of chronic obstructive pulmonary disease
J. Sun et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2018)
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease
Peter J. Barnes
NATURE REVIEWS IMMUNOLOGY (2018)
Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations
Olivier Le Rouzic et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
The Challenges of Precision Medicine in COPD
Mario Cazzola et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Serum IL-1 beta and IL-17 levels in patients with COPD: associations with clinical parameters
Yong Zou et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease
Andreas Eich et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
New Anti-Eosinophil Drugs for Asthma and COPD Targeting the Trait!
Elisabeth H. Bel et al.
CHEST (2017)
Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF
Abraham B. Roos et al.
RESPIRATORY RESEARCH (2017)
Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications
D. Robinson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
TSLP production by dendritic cells is modulated by IL-1 and components of the endoplasmic reticulum stress response
Matthew J. Elder et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema
Utako Fujii et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease
Maria Gabriella Matera et al.
DRUGS (2016)
Lung-resident eosinophils represent a distinct regulatory eosinophil subset
Claire Mesnil et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Increased IL-33 expression in chronic obstructive pulmonary disease
Jie Xia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis
Abraham B. Roos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD
Juan-juan Fu et al.
CHEST (2015)
PA401, a novel CXCL8-based biologic therapeutic with increased glycosaminoglycan binding, reduces bronchoalveolar lavage neutrophils and systemic inflammatory markers in a murine model of LPS-induced lung inflammation
Tiziana Adage et al.
CYTOKINE (2015)
Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation
L. Dejager et al.
MUCOSAL IMMUNOLOGY (2015)
Canakinumab for the treatment of chronic obstructive pulmonary disease
Paola Rogliani et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease
Osama Eltboli et al.
RESPIROLOGY (2015)
Identifying Molecular Targets for New Drug Development for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?
Peter J. Barnes
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
A Combinatorial Approach to Biophysically Characterise Chemokine-Glycan Binding Affinities for Drug Development
Tanja Gerlza et al.
MOLECULES (2014)
Mechanisms of pathogenesis in allergic asthma: Role of interleukin-23
Yanchun Li et al.
RESPIROLOGY (2014)
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study
Christopher E. Brightling et al.
LANCET RESPIRATORY MEDICINE (2014)
Expression analysis and specific blockade of the receptor for human thymic stromal lymphopoietin (TSLP) by novel antibodies to the human TSLPRα receptor chain
Andreas Borowski et al.
CYTOKINE (2013)
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers
Anne Kirsten et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma
Ozge Yilmaz et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial
Shawn D. Aaron et al.
THORAX (2013)
Function and mechanisms of TSLP/TSLPR complex in asthma and COPD
N. S. Redhu et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Emerging anti-inflammatory strategies for COPD
Mario Cazzola et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Viral Stimuli Trigger Exaggerated Thymic Stromal Lymphopoietin Expression by Chronic Obstructive Pulmonary Disease Epithelium: Role of Endosomal TLR3 and Cytosolic RIG-I-Like Helicases
Jenny Calven et al.
JOURNAL OF INNATE IMMUNITY (2012)
TNF-α inhibitors in asthma and COPD: We must not throw the baby out with the bath water
Maria Gabriella Matera et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease
Samy Suissa et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2008)
Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease
Keqin Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
TNF-alpha represses transcription of human Bone Morphogenetic Protein-4 in lung epithelial cells
Nian-Ling Zhu et al.
GENE (2007)
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease
Stephen I. Rennard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
E Gamble et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
First study of infliximab treatment in patients with chronic obstructive pulmonary disease
H van der Vaart et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD - A pilot study
DA Mahler et al.
CHEST (2004)
Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases
N Mukaida
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Share Paper
